These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7707699)

  • 1. Unreliable verification of prenatal diagnosis of Canavan disease: aspartoacylase activity in deficient and normal fetal skin fibroblasts.
    Rolland MO; Mandon G; Bernard A; Zabot MT; Mathieu M
    J Inherit Metab Dis; 1994; 17(6):748. PubMed ID: 7707699
    [No Abstract]   [Full Text] [Related]  

  • 2. Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): comparison of enzymatic and metabolite analysis.
    Bennett MJ; Gibson KM; Sherwood WG; Divry P; Rolland MO; Elpeleg ON; Rinaldo P; Jakobs C
    J Inherit Metab Dis; 1993; 16(5):831-6. PubMed ID: 8295397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spectrum of mutations of the aspartoacylase gene in Canavan disease in non-Jewish patients.
    Elpeleg ON; Shaag A
    J Inherit Metab Dis; 1999 Jun; 22(4):531-4. PubMed ID: 10407784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester prenatal diagnosis of Canavan disease.
    Rolland MO; Divry P; Mandon G; Thoulon JM; Fiumara A; Mathieu M
    J Inherit Metab Dis; 1993; 16(3):581-3. PubMed ID: 7609457
    [No Abstract]   [Full Text] [Related]  

  • 5. Prenatal diagnosis for Canavan disease: the use of DNA markers.
    Matalon R; Kaul R; Gao GP; Michals K; Gray RG; Bennett-Briton S; Norman A; Smith M; Jakobs C
    J Inherit Metab Dis; 1995; 18(2):215-7. PubMed ID: 7564250
    [No Abstract]   [Full Text] [Related]  

  • 6. Canavan disease: molecular basis of aspartoacylase deficiency.
    Kaul R; Gao GP; Balamurugan K; Matalon R
    J Inherit Metab Dis; 1994; 17(3):295-7. PubMed ID: 7528829
    [No Abstract]   [Full Text] [Related]  

  • 7. Prenatal diagnosis of Canavan disease.
    Matalon R; Michals-Matalon K
    Prenat Diagn; 1999 Jul; 19(7):669-70. PubMed ID: 10419617
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutation analysis of the aspartoacylase gene in non-Jewish patients with Canavan disease.
    Zeng BJ; Pastores GM; Leone P; Raghavan S; Wang ZH; Ribeiro LA; Torres P; Ong E; Kolodny EH
    Adv Exp Med Biol; 2006; 576():165-73; discussion 361-3. PubMed ID: 16802711
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel aspartoacylase (ASPA) gene mutation in Canavan disease.
    Durmaz AA; Akin H; Onay H; Vahabi A; Ozkinay F
    Fetal Pediatr Pathol; 2012 Aug; 31(4):236-9. PubMed ID: 22468686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Canavan disease: diagnosis and molecular analysis.
    Matalon R
    Genet Test; 1997; 1(1):21-5. PubMed ID: 10464621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSIEM Award. Aspartoacylase deficiency: the enzyme defect in Canavan disease.
    Matalon R; Kaul R; Casanova J; Michals K; Johnson A; Rapin I; Gashkoff P; Deanching M
    J Inherit Metab Dis; 1989; 12 Suppl 2():329-31. PubMed ID: 2512436
    [No Abstract]   [Full Text] [Related]  

  • 12. Canavan disease: biochemical and molecular studies.
    Matalon R; Kaul R; Michals K
    J Inherit Metab Dis; 1993; 16(4):744-52. PubMed ID: 8412017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspartoacylase gene knockout in the mouse: impact on reproduction.
    Surendran S; Szucs S; Tyring SK; Matalon R
    Reprod Toxicol; 2005; 20(2):281-3. PubMed ID: 15907664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease.
    Klugmann M; Leichtlein CB; Symes CW; Serikawa T; Young D; During MJ
    Mol Ther; 2005 May; 11(5):745-53. PubMed ID: 15851013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of aspartoacylase: implications for Canavan disease.
    Hershfield JR; Pattabiraman N; Madhavarao CN; Namboodiri MA
    Brain Res; 2007 May; 1148():1-14. PubMed ID: 17391648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis.
    Elpeleg ON; Shaag A; Anikster Y; Jakobs C
    J Inherit Metab Dis; 1994; 17(6):664-6. PubMed ID: 7707689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging in juvenile Canavan disease.
    Toft PB; Geiss-Holtorff R; Rolland MO; Pryds O; Müller-Forell W; Christensen E; Lehnert W; Lou HC; Ott D; Hennig J
    Eur J Pediatr; 1993 Sep; 152(9):750-3. PubMed ID: 8223809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutation of aspartoacylase gene in a Turkish patient with Canavan disease.
    Unalp A; Altiok E; Uran N; Oztürk A; Yüksel S
    J Trop Pediatr; 2008 Jun; 54(3):208-10. PubMed ID: 17999961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of human aspartoacylase: the brain enzyme responsible for Canavan disease.
    Le Coq J; An HJ; Lebrilla C; Viola RE
    Biochemistry; 2006 May; 45(18):5878-84. PubMed ID: 16669630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiometric assay for aspartoacylase activity in human fibroblasts: application for the diagnosis of Canavan's disease.
    Barash V; Flhor D; Morag B; Boneh A; Elpeleg ON; Gilon C
    Clin Chim Acta; 1991 Sep; 201(3):175-81. PubMed ID: 1756590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.